B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

AMPK inhibits chREBP transcriptional activation activity

REACTOME PATHWAY
Reactome: R-HSA-1636803 genes13 compounds

The AMPK inhibits chREBP transcriptional activation activity pathway (Reactome ID: R-HSA-163680) involves 3 genes and is affected by 13 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

PRKAA2PRKAB2PRKAG2

Compounds Affecting AMPK inhibits chREBP transcriptional activation activity

#CompoundTargets HitStudies
1Adenosine Monophosphate Adenine nucleotide containing300
2Proguanil299
3Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone76
4Niclosamide299
5Berberine300
6Ursolic Acid300
7Antimycin300
8Oleanolic Acid300
9Rotenone300
10Metformin1,000
11Quercetin300
12Kaempferols300
13Rutin300

About the AMPK inhibits chREBP transcriptional activation activity Pathway

The AMPK inhibits chREBP transcriptional activation activity pathway is catalogued in Reactome (ID: R-HSA-163680) and involves 3 genes. In the BiohacksAI corpus, 13 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include PRKAA2, PRKAB2, PRKAG2.